These versatile molecules are making significant strides in the treatment of a wide range of medical conditions, including chronic diseases, cancer, and severe chronic pain
Retatrutide is an investigational triple agonist that simultaneously stimulates the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, and it is being tested in phase 2 and phase 3 programs for obesity, type 2 diabetes, and metabolic dysfunctionassociated steatohepatitis
Otolaryngology-Head and Neck Surgery
Currently, Long-Acting GLP-1 Agonists Occupy the Largest Share of the GLP-1 Market Based on the type of GLP-1 agonists drugs, the market is segmented into short-acting GLP-1 agonist and long-acting GLP-1 agonist
For drinks, cold brew with no sweetener or a plain iced Americano are the cleanest choices